Categories
Tags
Abbott Advertising AstraZeneca Barack Obama Biotechnology and Pharmaceuticals Breast cancer Bristol Myers Squibb business Cancer Clinical trial Conditions and Diseases Deal Eli Lilly European Commission European Union FDA Food and Drug Administration Genentech generics GlaxoSmithKline Google GSK HBA Health Health care Johnson & Johnson layoffs Lilly Margaret Hamburg Marketing Merck Novartis Pfizer Pharma Pharmaceutical drug pharmaceutical industry Research and development Roche Sanofi-Aventis Schering Plough social media Twitter U.S. Food and Drug Administration United States Wyeth
Technology News
BioPharm News- Shire Gains European Approval for its Gaucher Disease Treatment
- Mtech Bioprocess Scale-Up Facility to Double in Staff and Size
- ImClone Closes Plant in New Jersey, Consolidating Erbitux Manufacture
- EMA and FDA Seek Applicants for Joint GMP Inspections
- ATMI Expands Bloomington, Minnesota Manufacturing Facility
Clinical Trials News- CRF Health Achieves EXACT ePRO Vendor Certification for Windows Mobile Systems
- ACR Image Metrix Establishes Global Presence
- BioPharm Systems Named to the 2010 Inc. 500|5000 List of Fastest-Growing Companies in the U.S.
- CRF Health Doubles North American Headquarters
- Oracle Completes Acquisition of Phase Forward
Blogroll
-
Meta
Tag Archives: Sanofi-Aventis
Pharma Unplugged #2 Layoffs & Bonuses
Pharma Unplugged #2— Layoffs & Bonuses
Recorded: 12/3/2009
Air Date: 12/7/2009
Host: George Koroneos, Pharm Exec
Cohost: Reid Paul, Pharm Rep Magazine
Show Notes:
This week we discuss:
Pfizer’s medical education relationship with the Canadian Medical Association
Journalists take FDA to task for not being transparent enough
Layoffs and job cuts at Sanofi-Aventis
New report shows that DTC receives more funding than sales calls in [...]
Posted in News, Podcasts Also tagged Canada, Food and Drug Administration, Medicine, pharma unplugged, podcast Leave a comment
Pharma Industry Booming in Eastern Europe
Eastern Europe’s pharmaceutical market is forecast to grow at a CAGR of more than 10 percent to be worth more than $41 billion by 2014, according to a report from globalbusinessinsights.com. The highest sales are expected to be seen in the cardiovascular market ($7.8 billion), followed by alimentary canal and metabolic disorders ($6 billion).
According to [...]
Posted in Global Also tagged business, Czech Republic, Eastern Europe, Novartis, Pharmaceutical drug, pharmaceutical industry, Slovenia Leave a comment
Latest News from ASCO: Winners, Losers, and Also Rans
Image via Wikipedia
Due to pharma’s voluntary moratorium on doling out totefuls of freebies and all the lattes you can swallow, thousands of docs, researchers, and reporters had only their sleep-deprived selves to carry from data dump to data dump at this week’s American Society of Clinical Oncology (ASCO) annual confab in Orlando, Florida.
Some 4,000 studies [...]
Posted in Events Also tagged AstraZeneca, Cancer, Chemotherapy, Clinical trial, Lung cancer, United States 1 Comment
Sanofi Executive Change Up
Barely a week after former Glaxo executive Chris Viehbacher assumed the role of CEO, Sanofi-Aventis announced that Jean-Claude Leroy, the company’s executive vp of finance and legal, has left the company. In a short statement, the company noted that his position will be filled by two people, reporting directly to Viehbacher; they are CFO [...]
Posted in People Also tagged CFO, Chris Viehbacher, Jean-Claude Leroy, Karen Linehan, Laurence Debroux Leave a comment

Genzyme Snubs Sanofi Offer